TWI510631B - A method of determining the susceptibility of drug-induced toxicity - Google Patents
A method of determining the susceptibility of drug-induced toxicityInfo
- Publication number
- TWI510631B TWI510631B TW103102867A TW103102867A TWI510631B TW I510631 B TWI510631 B TW I510631B TW 103102867 A TW103102867 A TW 103102867A TW 103102867 A TW103102867 A TW 103102867A TW I510631 B TWI510631 B TW I510631B
- Authority
- TW
- Taiwan
- Prior art keywords
- susceptibility
- drug
- determining
- induced toxicity
- toxicity
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103102867A TWI510631B (en) | 2014-01-27 | 2014-01-27 | A method of determining the susceptibility of drug-induced toxicity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103102867A TWI510631B (en) | 2014-01-27 | 2014-01-27 | A method of determining the susceptibility of drug-induced toxicity |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201529857A TW201529857A (en) | 2015-08-01 |
TWI510631B true TWI510631B (en) | 2015-12-01 |
Family
ID=54342575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103102867A TWI510631B (en) | 2014-01-27 | 2014-01-27 | A method of determining the susceptibility of drug-induced toxicity |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI510631B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI642784B (en) * | 2016-10-14 | 2018-12-01 | 國泰醫療財團法人國泰綜合醫院 | Usage of genotype sequences evaluating susceptibility to disease drug treatment |
-
2014
- 2014-01-27 TW TW103102867A patent/TWI510631B/en not_active IP Right Cessation
Non-Patent Citations (4)
Title |
---|
Ho HT et al., "The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity", Pharmacogenetics and Genomics, vol.23, no.4, p.200-207, 2013/04 * |
Lee SW et al., "NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis", The International Journal of Tuberculosis and Lung Disease, vol.14, no.5, p.622-626, 2010 * |
Shih TY et al., "A novel mechanism underlies the hepatotoxicity of pyrazinamide", Antimicrobial Agents and Chemotherapy, vol.57, no.4, p.1685-1690, 2013/01/28 * |
Tang S et al., "Cytochrome P450 2E1 gene polymorphisms/halotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort, PLOS ONE, volume 8, issue 2, e57526, 2013/02/27 * |
Also Published As
Publication number | Publication date |
---|---|
TW201529857A (en) | 2015-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201802206B (en) | Beam-scan time indicator | |
SG10202000449XA (en) | Impact analysis | |
GB2522781B (en) | Mark detecting method | |
GB2524479B (en) | Testing rig | |
GB2549014B (en) | Continuous locating while drilling | |
HK1245521A1 (en) | Determining the passing time of a moving transponder | |
GB2542547B (en) | Process cartridge | |
GB201408100D0 (en) | Detection method | |
EP2998732C0 (en) | Analysis method | |
GB201504103D0 (en) | A probe | |
GB201607639D0 (en) | Sensing method | |
IL252086A0 (en) | Novel methods | |
GB2540730B (en) | Time interval measurement | |
GB201419330D0 (en) | Detection method | |
HK1210267A1 (en) | Method for the measurement of a measurement object by means of -ray fluorescence | |
GB201416459D0 (en) | Detection method | |
GB201411567D0 (en) | Quantification methods | |
TWI510631B (en) | A method of determining the susceptibility of drug-induced toxicity | |
SG11201702732UA (en) | Oxidant-dependent time indicator | |
GB2523628B (en) | Bricklaying jig | |
GB2523732B (en) | Tritium measurement | |
IL230670A0 (en) | Elapsed time indicator | |
GB201402174D0 (en) | Detection method | |
GB201401612D0 (en) | Synthetic method | |
GB2562659B (en) | Inflow indicator apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |